Vijaya Iyer is a freelance science writer for BioNews Services. She has contributed content to their several disease-specific websites, including cystic fibrosis, multiple sclerosis, muscular dystrophy, among others.
She holds a PhD in Microbiology from Kansas State University, where her research focused on molecular biology, bacterial interactions, metabolism, and animal models to study bacterial infections. Following the completion of her PhD, Dr. Iyer went on to complete three postdoctoral fellowships at Kansas State University, University of Miami and Temple University.
She joined BioNews Services to utilize her scientific background and writing skills to help patients and caregivers remain abreast with important scientific breakthroughs.
Hospitalization markedly increases the costs of bronchiectasis care and management, especially in patients who experience flare-ups, a review of published studies shows. The study with that finding, “The economic ... Read more
A rare infection of the trachea with the bacteria Achromobacter xylosoxidans deteriorated the respiratory function of an idiopathic bronchiectasis patient, a case study reports. The U.K. case report “Achromobacter xylosoxidans in ... Read more
Endoscopic sinus surgery to relieve nasal inflammation in bronchiectasis patients with chronic rhinosinusitis (CRS) positively influences health-related quality of life but does not seem to improve lung function, a ... Read more
Improvements in physical ability as seen with the incremental shuttle walk test (ISWT) mirror pulmonary function improvements in bronchiectasis patients, a study reports, indicating that the test could serve as ... Read more
The mixture of 0.1% hyaluronic acid and 7% hypertonic saline (HS) can serve as an alternative inhalation therapy for bronchiectasis patients who are intolerant to 7% HS alone, a ... Read more
Pin It on Pinterest